Literature DB >> 25092942

Severe complications in influenza-like illnesses.

Rakesh D Mistry1, Jason B Fischer2, Priya A Prasad3, Susan E Coffin4, Elizabeth R Alpern5.   

Abstract

OBJECTIVE: Data on complications from upper respiratory infection are limited. We examined development of severe complications in children presenting to the emergency department (ED) for moderate to severe influenza-like illness (ILI).
METHODS: Prospective cohort study of children 0 to 19 years presenting to a tertiary care children's hospital ED during peak respiratory viral seasons from 2008 to 2010. Subjects included had moderate to severe ILI, defined by performance of venipuncture and nasopharyngeal multiplex polymerase chain reaction for respiratory viruses. Severe complications (respiratory failure, encephalopathy, seizures, pneumonia, bacteremia, death) were prospectively determined. Risk factors for severe complications were collected, including demographics, comorbidities, and household exposures.
RESULTS: There were 241 enrolled subjects with median age of 27.4 months (interquartile range 8.9-68.5); 59.3% were boys and 48.5% were black. High-risk conditions were present in 53.5%. Severe complications developed in 35.3% (95% confidence interval [CI] 29.3-41.3), most frequently pneumonia (26.1%). The risk for severe complications was increased in subjects with neurologic or neuromuscular conditions (relative risk 4.0; 95% CI 1.9-8.2). No specific respiratory virus was associated with development of severe complications. Among patients with influenza, severe complications were greater with subtype H1N1 infection (relative risk 1.45, 95% CI 0.99-2.13, P = .048), and were at highest risk for pneumonia (relative risk 4.2, 95% CI 1.2-15.9).
CONCLUSION: In children presenting to the ED for moderate to severe ILI, those with neurologic and neuromuscular disease are at increased risk for severe complications. Development of severe complications did not differ by infecting virus; however, risk of severe complications was greater with subtype H1N1 compared with other influenza.
Copyright © 2014 by the American Academy of Pediatrics.

Entities:  

Keywords:  pandemic influenza; pneumonia; viral respiratory infection

Mesh:

Year:  2014        PMID: 25092942     DOI: 10.1542/peds.2014-0505

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  6 in total

1.  Vaccine hesitancy and influenza beliefs among parents of children requiring a second dose of influenza vaccine in a season: An American Academy of Pediatrics (AAP) Pediatric Research in Office Settings (PROS) study.

Authors:  Ekaterina Nekrasova; Melissa S Stockwell; Russell Localio; Justine Shults; Chelsea Wynn; Laura P Shone; Lindsay Berrigan; Chelsea Kolff; Miranda Griffith; Andrew Johnson; Alessandra Torres; Douglas J Opel; Alexander G Fiks
Journal:  Hum Vaccin Immunother       Date:  2020-02-04       Impact factor: 3.452

2.  Does the Influenza Vaccine Prevent Sequelae Such as Myocarditis from Developing?

Authors:  Ryan Whitney; Jason Dazley; Ryan Gilbert; Jihad Slim
Journal:  J Glob Infect Dis       Date:  2015 Jul-Sep

3.  Detection of viral respiratory pathogens in mild and severe acute respiratory infections in Singapore.

Authors:  Lili Jiang; Vernon Jian Ming Lee; Lin Cui; Raymond Lin; Chyi Lin Tan; Linda Wei Lin Tan; Wei-Yen Lim; Yee-Sin Leo; Louie Low; Martin Hibberd; Mark I-Cheng Chen
Journal:  Sci Rep       Date:  2017-02-20       Impact factor: 4.379

Review 4.  Vaccination against Paediatric Respiratory Pathogens.

Authors:  Sonia Bianchini; Alberto Argentiero; Barbara Camilloni; Ettore Silvestri; Anna Alunno; Susanna Esposito
Journal:  Vaccines (Basel)       Date:  2019-11-01

5.  The burden of influenza and other respiratory viruses in hospitalized infants and children in a university hospital, Jordan.

Authors:  Enas Al-Zayadneh; Dina Mohammad Abu Assab; Esraa Adeeb Arabiat; Montaha Al-Iede; Hanin Ahmad Kayed; Amirah Daher
Journal:  Multidiscip Respir Med       Date:  2021-11-11

6.  Hospital utilization rates for influenza and RSV: a novel approach and critical assessment.

Authors:  Emily K Johnson; Dillon Sylte; Sandra S Chaves; You Li; Cedric Mahe; Harish Nair; John Paget; Tayma van Pomeren; Ting Shi; Cecile Viboud; Spencer L James
Journal:  Popul Health Metr       Date:  2021-06-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.